Nicotine Analogs and the Next Regulatory Frontier: Emerging Questions for Science, Policy, and Product Governance

Inspired by commentary from Chris Allen on discussions surrounding the 10th Keller and Heckman Symposium. As global nicotine regulation continues to evolve, one of the more technically complex and strategically significant emerging issues is the rise of nicotine analogs, compounds structurally related to nicotine that may increasingly challenge existing regulatory definitions, product classifications, and enforcement…

Argentina Rewrites Its Nicotine Policy Framework: From Prohibition to Regulatory Integration

Argentina has formally entered a new era in nicotine product governance. With the publication of Resolution 549/2026, the Ministry of Health has replaced a longstanding prohibition-centered framework with a structured regulatory system for innovative nicotine products (INPs), including vaping products, heated tobacco products, and nicotine pouches. Framed domestically as the “fin de la prohibición,” Argentine…

France’s Nicotine Pouch Ban and Europe’s Regulatory Divide: What It Reveals About EU Policy Fragmentation

France’s recent move to prohibit nicotine pouches has intensified debate across Europe over how emerging nicotine products should be governed within the European Union’s legal and regulatory architecture. The decision has drawn attention not only because of its domestic implications, but because it highlights a broader and increasingly visible challenge within Europe: regulatory fragmentation between…

From Pilot to Precedent: How FDA’s Nicotine Pouch Program May Reshape Premarket Review

Inspired by analysis from Andrew Mooney of Broughton Group and broader discussions emerging from ATNF 2026. The U.S. Food and Drug Administration’s recent nicotine pouch pilot program may prove to be one of the most consequential regulatory developments for reduced-risk nicotine products in years, not because it lowered standards, but because it demonstrated that speed…

Taxation and Market Surveillance: Navigating Policy Complexity in the EU and Beyond

At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how taxation frameworks and market surveillance systems are shaping the regulation and development of alternative nicotine products across the EU and beyond. The session was moderated by Ciprian Boboi and featured contributions from Tomasz Płaska, Leonhard Kipphan, and Lorenzo…

Innovation and Acceptance: Understanding Consumer Choice in New Nicotine Products

At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a panel session exploring the factors influencing consumer adoption of new nicotine products, focusing on innovation, accessibility, and regulatory context. The session was moderated by Marc Reisner and featured contributions from Waqas Khan, Vincent Reid, and John Dunne, offering perspectives from manufacturing, distribution, and…

Navigating EU Taxation for Alternative Nicotine Products: Key Insights from EVO NXT 2026

At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how evolving EU taxation frameworks are shaping the regulation, availability, and market dynamics of alternative nicotine products. The session was hosted by Joel Rubenstein and featured contributions from Johan Nissinen, Ciprian Boboi, Vlad Olteanu, and Tomasz Płaska, bringing together…

Tobacco Harm Reduction: Latest Science and Public Health Perspectives from EVO NXT 2026

At EVO NXT 2026, the Global Institute for Novel Nicotine opened its programme with a panel session examining the latest scientific evidence, regulatory frameworks, and public health considerations surrounding tobacco harm reduction. The session was moderated by Philipp Markl and featured contributions from Dr Sydney Hiller, Sairah Salim-Sartoni, and John Dunne, bringing together perspectives from…